Showing results (1251-1260 of 3,182) with videos related to

Sort By:
Pageof 319
Translational Oncology|August 13, 2021
Oncosuppressive role of MicroRNA-205-3p in gastric cancer through inhibition of proliferation and induction of senescence: Oncosuppressive role of MicroRNA-205 in gastric cancerXiaoyu Ma, Naiqian Wang, Keyan Chen, et al.
Translational Oncology|August 13, 2021
Loss of FAM60A attenuates cell proliferation in glioma via suppression of PI3K/Akt/mTOR signaling pathwaysXiaocen Liu, Mengying Zhang, Xiaolong Zhu, et al.
Translational Oncology|August 1, 2021
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitorsJonathan W Riess, Shaila Rahman, Waleed Kian, et al.
Translational Oncology|September 9, 2021
TRPC5 mediates TMZ resistance in TMZ-resistant glioblastoma cells via NFATc3-P-gp pathwayYan Zou, Zi'xiang Liu, Yi'nan Zhou, et al.
Translational Oncology|February 12, 2023
Circular RNA circFBXO7 attenuates non-small cell lung cancer tumorigenesis by sponging miR-296-3p to facilitate KLF15-mediated transcriptional activation of CDKN1AZi-Hao Wang, Lin-Lin Ye, Xuan Xiang, et al.
Translational Oncology|February 15, 2023
Sunitinib versus imatinib dose escalation after failure of imatinib standard dose in patients with advanced Gastrointestinal stromal tumors - a real-world multi-center studyShaoqing Huang, Xing Liu, Xiaodan Guo, et al.
Translational Oncology|March 1, 2023
Retinoic acid-loaded PLGA nanocarriers targeting cell cholesterol potentialize the antitumour effect of PD-L1 antibody by preventing epithelial-mesenchymal transition mediated by M2-TAM in colorectal cancerRaimundo Fernandes de Araújo Júnior, George A Lira, Timo Schomann, et al.
Translational Oncology|March 3, 2023
Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasesQiuyue Ye, Yan Xu, Jing Zhao, et al.
Translational Oncology|March 22, 2023
Downregulation of miR-221-3p promotes the ferroptosis in gastric cancer cells via upregulation of ATF3 to mediate the transcription inhibition of GPX4 and HRD1Chang-Jiang Shao, Hai-Lang Zhou, Xu-Zhu Gao, et al.
Translational Oncology|November 15, 2022
PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1Lihua Liu, Aihua Liu, Xuezheng Liu
Pageof 319